← 返回

探索间充质干细胞分泌组的两面性:经细胞信号通路调控肿瘤的启示

英文原题:Exploring the dichotomy of the mesenchymal stem cell secretome: Implications for tumor modulation via cell-signaling pathways.

查看英文原题

Exploring the dichotomy of the mesenchymal stem cell secretome: Implications for tumor modulation via cell-signaling pathways.

PubMed 2024/09/30(内容时间) Int Immunopharmacol Q1 · IF 5.6(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

由于不良副作用和耐药性,当前许多癌症治疗策略往往未能取得成功。因此,设计和开发强效的新型抗癌平台(如干细胞治疗)受到广泛关注。干细胞的独特生物学特性包括分泌生物活性因子、免疫原性较低以及自我更新能力。间充质干细胞(MSC)是多种干细胞类型之一,可从不同来源较方便地获取,并能在体外培养。干细胞分泌组含有多种营养因子,包括细胞因子、趋化因子、生长因子和 microRNA 分子;根据细胞所处环境,这些因子既可能促进也可能抑制肿瘤形成。本综述聚焦 MSC 分泌组。MSC 在调节细胞信号转导通路方面具有双刃剑作用,既可能抑制肿瘤,也可能促进肿瘤。

展开英文摘要原文

Current cancer therapeutic strategies for the treatment of cancer are often unsuccessful due to unwanted side effects and drug resistance.

Therefore, the design and development of potent, new anticancer platforms, such as stem-cell treatments, have attracted much attention. Distinctive biological properties of stem cells include their capacity to secrete bioactive factors, their limited immunogenicity, and their capacity for renewing themselves. Mesenchymal stem cells (MSCs) are one of several kinds of stem cells that are conveniently extracted and are able to be cultivated in vitro utilizing various sources.

The secretome of stem cells contains many trophic factors, including cytokines, chemokines, growth factors, and microRNA molecules that can either promote or inhibit the formation of tumors, based on the cell environment. In the current review, we focused on the secretome of mesenchymal stem cells. These stem cells act as a double-edged sword in the regulation of cell signal transduction pathways in that they can either suppress or promote tumors.

论文信息

作者
Rasouli M、Alavi M、D'Angelo A、Sobhani N、Roudi R、Safari F
第一作者单位
Department of Biology, Faculty of Science, University of Guilan, Rasht, Iran.Iran
通讯作者单位
Department of Biology, Faculty of Science, University of Guilan, Rasht, Iran. Electronic address: fsafari@guilan.ac.ir.Iran
文献类型
综述
期刊
International immunopharmacology2024 Dec 25
原文标识
PubMed 39353385 · DOI 10.1016/j.intimp.2024.113265